Скачать
The development and preclinical activity of CMS121, a fisetin derivative, in AD
Автор: VJDementia
Загружено: 2026-01-13
Просмотров: 10
Описание:
Pamela Maher, PhD, Salk Institute for Biological Studies, San Diego, CA, discusses the development of CMS121, a fisetin derivative being explored for the treatment of Alzheimer's disease (AD). This novel drug candidate has multiple targets in the ageing brain and has shown activity in AD mouse models. This interview took place at the 18th Clinical Trials on Alzheimer's Disease (CTAD) Conference in San Diego, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Не удается загрузить Youtube-плеер. Проверьте блокировку Youtube в вашей сети.
Повторяем попытку...
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке:
